เปิดทำการกี่โมง?

จันทร์ 09:00 - 17:00 อังคาร 09:00 - 17:00 พุธ 09:00 - 17:00 พฤหัสบดี 09:00 - 17:00 ศุกร์ 09:00 - 17:00

The Regeneration Center

Stem Cell Regeneration Center is dedicated to providing regenerative stem cell treatments in Thailan

Stem Cell Regeneration Center of Thailand "SCT" is dedicated to providing regenerative stem cell treatments for many degenerative conditions.

05/08/2025

Body Mass Index (BMI) has long been the standard for assessing obesity, but its limitations are increasingly recognized. A recent study from the University of Florida suggests that Bioelectrical Impedance Analysis (BIA) could serve as a more accurate alternative. BMI, which only considers height and weight, often misclassifies individuals, particularly athletes with high muscle mass or those with excess visceral fat despite a normal BMI. The study analyzed over 4,000 adults and found that BIA, which measures body fat percentage using electrical currents, better predicts health risks. Results indicated that individuals with higher body fat percentages faced significantly increased mortality risks, with men over 27% and women over 44% body fat being particularly vulnerable. While BMI is simple and cost-effective, the medical community is beginning to acknowledge the need for more nuanced measurements like BIA to better assess health risks associated with body composition.

BMI is still commonly used to assess obesity even though research has shown it's not necessarily a reliable metric. A new study proposes doctors instead use technology that can measure body fat.

04/08/2025

Recent studies suggest that the diabetes and weight loss drug Ozempic may have protective effects against strokes. Presented at the Society of NeuroInterventional Surgery's annual meeting, three studies indicate that GLP-1 inhibitors like Ozempic could significantly reduce stroke mortality rates, enhance recovery from brain injuries, and potentially lower the overall risk of stroke. One study analyzed data from over two million stroke patients, revealing that those on Ozempic had a markedly lower death rate from strokes compared to non-users. Another study found a correlation between Ozempic use and reduced odds of experiencing a stroke. The third study examined outcomes after brain hemorrhages and strokes, showing that GLP-1 inhibitors were linked to fewer cognitive side effects and improved survival rates. Researchers emphasize the need for further investigation to fully understand the implications of these findings, which could reshape treatment approaches for stroke patients.

Could popular diabetes and weight loss drugs like Ozempic actually protect your brain from stroke damage, or prevent strokes altogether? Three new studies presented at a major neurosurgery conference suggest they might.

02/08/2025

Recent research highlights the effectiveness of targeted deep brain stimulation (DBS) in improving walking abilities in individuals with spinal cord injuries. This innovative approach focuses on stimulating specific brain regions to enhance motor function and mobility. The study demonstrates that by precisely targeting areas of the brain involved in movement control, patients experience significant improvements in their ability to walk. This breakthrough offers new hope for rehabilitation strategies aimed at restoring mobility in those affected by spinal cord injuries, potentially transforming the landscape of recovery and rehabilitation. As researchers continue to explore the mechanisms behind this technique, the findings underscore the importance of integrating advanced neurological interventions in the treatment of spinal cord injuries.

Targeted deep brain stimulation improves walking after injury

30/07/2025

The critical link between diet and kidney health, emphasizes the role of nutrition in managing kidney disease. It highlights the importance of incorporating specific foods known as "superfoods" that can help prevent fatty acid oxidation, a process that can lead to chronic kidney issues. The Regeneration Center, a leader in regenerative medicine, shares insights from over a decade of experience in treating kidney diseases with renal stem cells. The article explains how excessive oxidation can produce harmful free radicals, damaging vital proteins and DNA. By understanding the relationship between diet and kidney function, individuals can take proactive steps to maintain their kidney health and potentially prevent chronic conditions.

Every day, it seems, medical researchers discover new links connecting chronic diseases, systemic inflammation, and the significance of what are known as “superfoods” in preventing or protecting against unwelcome fatty acid oxidation. It should come…

29/07/2025

The US FDA has approved Yeztugo, an effective HIV prevention drug, marking a significant milestone in the fight against HIV. This innovative drug requires only two injections per year, offering nearly complete protection against the virus. With approximately 1.3 million new HIV infections annually, this breakthrough could save millions of lives globally. Gilead is committed to making Yeztugo accessible by waiving royalties and partnering with six generic manufacturers to produce the drug affordably. The approval follows lenacapavir's earlier success as a treatment for those already infected. Experts believe that Yeztugo could transform HIV prevention by addressing barriers such as adherence and stigma associated with daily oral PrEP regimens. Gilead is also seeking regulatory approvals in multiple countries, including Australia and Brazil, and has established programs to assist uninsured individuals in accessing the medication at no cost. This development is hailed as a historic achievement in the ongoing battle against the HIV epidemic.

An epidemic that's been sustained for 44 years might finally be quelled, with the milestone approval of the first HIV drug that offers 100% protection with its twice-yearly injections. It's a landmark achievement that stands to save millions of lives across the globe. The makers are also providing.....

24/07/2025

Recent research from Johns Hopkins Medicine reveals that radiation therapy can enhance the immune system’s ability to combat certain lung cancers, particularly those resistant to immunotherapy. By combining radiation with immunotherapy, researchers found that previously unresponsive tumors could be transformed into targets for immune attack. This occurs through a systemic activation of immune cells, not limited to the radiation site, leading to significantly improved patient outcomes. The study highlights the potential of radiation therapy to overcome immunotherapy resistance, offering new hope for patients with hard-to-treat cancers. The findings, published in Nature Cancer, emphasize the importance of understanding the molecular mechanisms behind this phenomenon, known as the abscopal effect, which allows the immune system to recognize and attack cancer cells beyond the primary tumor site. This innovative approach could change treatment strategies for lung cancer patients, particularly those with tumors that exhibit resistance to conventional therapies.

Radiation therapy, once thought of mainly as a local cancer treatment, is now showing power to awaken the immune system in surprising ways. Researchers discovered that combining radiation with immunotherapy can transform stubborn, unresponsive lung tumors into targets for immune attack—especially ...

16/07/2025

Researchers examined how aging alters the balance between cerebrospinal fluid (CSF) and plasma proteins, particularly in relation to cognitive impairment. Using SomaScan proteomics, they analyzed matched CSF and plasma samples from 2,171 older adults both cognitively healthy and impaired across multiple cohorts. The study identified proteins with correlated concentrations in both fluids and found that aging significantly changes CSF-to-plasma ratios for many of them, including proteins implicated in neurodegeneration. Interestingly, some proteins linked to preserved cognitive function exhibited increased CSF-to-plasma ratios with age. Genome-wide association analyses further revealed genetic loci influencing these protein ratios, many of which are tied to known disease pathways. These findings shed light on age-related disruption of the brain’s barrier systems and point to potential targets for brain-permeable therapeutic development.

Proteomic analysis of paired cerebrospinal fluid and plasma samples from 2,171 individuals drawn from multiple cohorts, including the Global Neurodegeneration Proteomics Consortium, reveals age-related changes in the ratios of proteins in the cerebrospinal fluid and plasma that are associated with c...

15/07/2025

Researchers have developed a new protocol for a randomized trial aimed at evaluating the effectiveness of a digital intervention designed to address alcohol consumption among risky drinkers. Despite existing macro-level interventions, harmful alcohol consumption remains prevalent. The study will employ a three-arm, parallel-group design to evaluate the impact of personalized interventions targeting individual motives for drinking and readiness to change behavior. Participants aged 18 and older will be recruited through web advertisements and social media. They will be divided into two intervention groups: one receiving a standard personalized digital intervention and the other receiving an enhanced version tailored specifically to their drinking motives and readiness to change. The intervention includes weekly screenings, personalized feedback, and behavior planning tools. The trial aims to provide insights into how tailored approaches can improve individual-level interventions for alcohol-related issues.

This website is using a security service to protect itself from online attacks. The action you just performed triggered the security solution. There are several actions that could trigger this block including submitting a certain word or phrase, a SQL command or malformed data.

13/07/2025

A new protocol has been developed for a systematic review and network meta-analysis focused on immunomodulatory therapies in the treatment of community-acquired pneumonia (CAP). CAP is a leading cause of infection-related mortality worldwide, with some patients experiencing severe immune responses that lead to inflammation and tissue damage. The review aims to evaluate the effectiveness of various immunomodulatory therapies in reducing mortality rates among hospitalized patients diagnosed with CAP. The primary objectives include comparing the impact of these therapies on 28-day and 90-day mortality rates, while secondary objectives will explore their effectiveness across different pneumonia types and severities. A comprehensive literature search will be conducted across multiple databases, to gather relevant studies for analysis.

12/07/2025

A recent study investigated the potential link between gabapentin prescriptions and the risk of dementia in adults suffering from chronic low back pain. Utilizing a national database, researchers analyzed data from 26,416 patients, excluding those with prior gabapentin use or other cognitive-affecting conditions. The findings revealed that patients receiving six or more prescriptions of gabapentin exhibited a significantly higher incidence of dementia (relative risk: 1.29) and mild cognitive impairment (relative risk: 1.85). Notably, non-elderly adults (ages 18-64) prescribed gabapentin faced more than double the risk of developing dementia (relative risk: 2.10) compared to those not prescribed the medication. The risk escalated with increased prescription frequency, with patients receiving 12 or more prescriptions showing an even greater incidence of cognitive decline. These results suggest a concerning association between gabapentin use and cognitive impairment, warranting further investigation into its long-term effects on brain health in chronic pain patients.

Online ISSN: 1532-8651Print ISSN: 1098-7339 Copyright © 2025 BMJ Publishing Group Ltd & American Society for Regional Anesthesia & Pain Medicine. All rights, including for text and data mining, AI training, and similar technologies, are reserved.

09/07/2025

Recent research has revealed that adults can indeed grow new neurons, a process known as neurogenesis. This groundbreaking discovery challenges the long-held belief that neurogenesis only occurs during embryonic development. The brain generates approximately 700 to 1,000 new neurons daily, primarily in the hippocampus, subventricular zone, and dentate gyrus, which are crucial for learning and memory. Neural stem cells (NSCs) play a vital role in this process, replenishing damaged cells and contributing to brain repair mechanisms. Advances in stem cell research, including induced pluripotent stem cell (iPSC) technology and 3D organoid cultures, have opened new avenues for understanding brain function and developing therapies for neurological disorders like Alzheimer’s and Parkinson’s disease. However, translating these findings into effective clinical treatments remains a challenge, necessitating further exploration of NSCs and their microenvironments. This shift in understanding neurogenesis marks a significant milestone in neuroscience, paving the way for potential breakthroughs in regenerative medicine.

Stem Cell Therapy & Modern Regenerative Medical Solutions using Mesenchymal (MSC+) Cells with Functional Healthcare

08/07/2025

Review investigated the relationship between fertility therapies and stroke risk in women, particularly focusing on those with a history of stroke. As assisted reproductive technologies (ARTs) become more prevalent, understanding their implications for stroke survivors is crucial. Out of the studies reviewed, only ten met the inclusion criteria, revealing a significant gap in high-quality prospective cohort studies. Notably, the review highlights that the existing literature lacks robust data on the safety and effectiveness of ARTs for stroke survivors, with only one prospective cohort study identified. This study included 32 pregnancies, with limited details on the stroke type and ART protocols used. The findings underscore the need for further research to clarify the risks associated with fertility treatments in this vulnerable population, aiming to inform clinical practices and future studies.

Objectives Fertility therapies are becoming an increasingly common option for conception, but there is little knowledge on the interactions of assisted reproductive technology (ARTs) and stroke in women, and its use among women with a history of stroke. This scoping review aims to examine the curren...

ที่อยู่

725 Sukhumvit Road
Bangkok
10110

เวลาทำการ

จันทร์	09:00 - 17:00
อังคาร	09:00 - 17:00
พุธ	09:00 - 17:00
พฤหัสบดี	09:00 - 17:00
ศุกร์	09:00 - 17:00

เบอร์โทรศัพท์

+66808069391

เว็บไซต์

https://stemcellthailand.org/

แจ้งเตือน

รับทราบข่าวสารและโปรโมชั่นของ The Regeneration Centerผ่านทางอีเมล์ของคุณ เราจะเก็บข้อมูลของคุณเป็นความลับ คุณสามารถกดยกเลิกการติดตามได้ตลอดเวลา

ติดต่อ การปฏิบัติ

ส่งข้อความของคุณถึง The Regeneration Center:

ชื่อ:

ที่อยู่อีเมล์:

ข้อความ:

ทางลัด

แชร์

Regenerative Non-Surgical Medical Solutions

Stem Cell Regeneration Center of Thailand "SCT" is dedicated to providing regenerative stem cell treatments for many degenerative conditions. Our specialty as a biotech company that manufactures best-in-class, allogeneic, adult stem cells and stem cell-derived factors.

Bluework ออกแบบตกแต่งร้านขายยา